FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, specifically to therapy, and concerns the treatment of diseases accompanied by a disturbance of the water balance. To this end, an effective amount of a compound selected from
, 
and 
.
EFFECT: this provides effective treatment of diseases such as edema of the brain and spinal cord of various etiologies, retinal edema, congestive heart failure and the rest, due to the selective inhibition of aquaporin.
57 cl, 13 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS | 2014 |
|
RU2691951C2 |
| MODULATION OF AQUAPORINS WITH RELAXIN | 2011 |
|
RU2564900C2 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME FOR PATIENTS IN CHRONIC CRITICAL CONDITION DUE TO CEREBRAL ACCIDENTS COMPLICATED BY PNEUMONIA | 2024 |
|
RU2822966C1 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| METHOD OF MYOCARDIUM INFARCTION TREATMENT | 2003 |
|
RU2330665C2 |
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| METHOD FOR TREATING ISCHEMIA AND CEREBRAL LESION WITH A NEUROPROTECTOR PREPARATION | 1996 |
|
RU2194527C2 |
| 7-HYDROXYEPIANDROSTERON WITH NEUROPROTECTIVE ACTIVITY | 2001 |
|
RU2307654C2 |
| METHOD OF REDUCING DEMAGE TO NERVOUS CELLS | 2007 |
|
RU2464977C2 |
| METHOD FOR GLIBENCLAMIDE PHARMACEUTICAL COMPOSITION PREPARATION IN FORM OF INJECTION SOLUTION | 2016 |
|
RU2615368C1 |
